Mangoceuticals (MGRX) Income from Continuing Operations (2023 - 2026)
Mangoceuticals (MGRX) reported Income from Continuing Operations of 3403141.0 for Q1 2026, up 29.68% on a YoY basis from 2624265.65 in Q1 2025, and down 22.89% sequentially from 2769370.0 in Q4 2025.
Mangoceuticals (MGRX) Income from Continuing Operations (2023 - 2026) Analysis & Trends
Mangoceuticals (MGRX) has 4 years of Income from Continuing Operations data on file, last reported at 3403141.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 29.68% year-over-year to 3403141.0; the trailing twelve-month figure through Mar 2026 stood at 19207107.0 (down 71.81% YoY), and the FY2025 full-year result was 16308330.0, down 137.08% from the prior year.
- Income from Continuing Operations declined to 3403141.0 in Q1 2026, from 2769370.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 1799460.0 in Q3 2023 to a low of 7618776.0 in Q3 2025.
- A 4-year average of 3228172.23 and a median of 2560885.0 in 2023 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations tumbled 281.0% in 2025 and grew 29.68% in 2026, its largest moves.
- Tracing MGRX's Income from Continuing Operations over 4 years: stood at 2568047.0 in 2023, then advanced by 24.12% to 1948596.0 in 2024, then plunged by 42.12% to 2769370.0 in 2025, then decreased by 22.89% to 3403141.0 in 2026.
- Business Quant data shows MGRX's Income from Continuing Operations at 3403141.0 in Q1 2026, 2769370.0 in Q4 2025, and 7618776.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.25 Bn | 24.94 Bn | 662.02 Mn | 260.94 Mn |
| 2 | BrightSpring Health Services | 14.59 Bn | 13.69 Bn | 482.22 Mn | 74.28 Mn |
| 3 | Healthequity | 8.34 Bn | 8.08 Bn | 256.31 Mn | 69.42 Mn |
| 4 | Hinge Health | 5.99 Bn | 5.67 Bn | 154.23 Mn | 35.13 Mn |
| 5 | 10x Genomics | 5.88 Bn | 5.34 Bn | 106.18 Mn | -13.47 Mn |
| 6 | MiniMed | 4.50 Bn | 4.20 Bn | 480.00 Mn | -185.00 Mn |
| 7 | Waystar Holding | 4.47 Bn | 4.41 Bn | 216.84 Mn | 43.28 Mn |
| 8 | Doximity | 3.97 Bn | 3.22 Bn | 125.97 Mn | 19.11 Mn |
| 9 | Privia Health | 3.13 Bn | 2.71 Bn | - | 3.71 Mn |
| 10 | Mangoceuticals | 8.95 Mn | 8.76 Mn | 29,001.00 | -3.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.40 Mn |
| Dec 31, 2025 | -2.77 Mn |
| Sep 30, 2025 | -7.62 Mn |
| Jun 30, 2025 | -5.42 Mn |
| Mar 31, 2025 | -4.84 Mn |
| Dec 31, 2024 | -1.95 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Jun 30, 2024 | -2.39 Mn |
| Mar 31, 2024 | -2.37 Mn |
| Dec 31, 2023 | -2.57 Mn |
| Sep 30, 2023 | -1.80 Mn |
| Jun 30, 2023 | -2.28 Mn |
| Mar 31, 2023 | -2.56 Mn |